CN1270053A - Medicine for treating rheumatic arthritis and hyperosteogeny and preparing process thereof - Google Patents

Medicine for treating rheumatic arthritis and hyperosteogeny and preparing process thereof Download PDF

Info

Publication number
CN1270053A
CN1270053A CN 99113955 CN99113955A CN1270053A CN 1270053 A CN1270053 A CN 1270053A CN 99113955 CN99113955 CN 99113955 CN 99113955 A CN99113955 A CN 99113955A CN 1270053 A CN1270053 A CN 1270053A
Authority
CN
China
Prior art keywords
radix
medicine
hyperosteogeny
rhizoma
herba
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN 99113955
Other languages
Chinese (zh)
Other versions
CN1074676C (en
Inventor
马焕召
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN99113955A priority Critical patent/CN1074676C/en
Publication of CN1270053A publication Critical patent/CN1270053A/en
Application granted granted Critical
Publication of CN1074676C publication Critical patent/CN1074676C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A Chinese medicine for treating rheumatic arthritis, hyperosteogeny, lumbar muscle strain, mastoplasia and galactocele is prepared from 15 Chinese-medicinal materials including phryma leptostachya, raw pinellia tuber, rhubarb, raw Sichuan aconite root, camphor, etc. Its advantages are high and quick curative effect, short course of treatment and no toxic by-effect.

Description

A kind of medicine for the treatment of rheumatic arthritis, hyperosteogeny and preparation method thereof
The present invention relates to medicine, especially relate to a kind of medicine for the treatment of rheumatic arthritis, hyperosteogeny and preparation method thereof.
In China, osteopathia such as rheumatic arthritis, hyperosteogeny all are comparatively common difficult and complicated illness.The neuralgia that the contrafluxion that rheumatic lumbago, lumbar muscle strain, knee joint, anconitis and wound cause, swelling, hyperosteogeny, spur in heels and prolapse of intervertebral disc cause, bring great misery to extensive patients, their study, work and life have seriously been influenced, What is more has almost lost work capacity, spirit also is subjected to enormous pressure, easily produces unhealthy emotions such as pessimism, disappointment.The oral medicine of many treatment rheumatic arthritis, hyperosteogeny, shortcomings such as ubiquity unsatisfactory curative effect, easy recurrence, and many medicament toxic side effects are arranged; And common cream class medicine and general application compress can only be removed the hardship in a period of time of patient mostly.
The object of the present invention is to provide and a kind ofly can effectively treat osteopathia such as rheumatic arthritis, hyperosteogeny, have no side effect, the medicine of good effect, instant effect and preparation method thereof.
The object of the present invention is achieved like this: medicine of the present invention is made (by weight percentage) by following component and is:
Herba speranskiae tuberculatae: 5~11% Radix Angelicae Pubescentiss: 3~9% Semen Sinapis Albaes: 1~7%
Give birth to half time: 5~11% Herba Lycopodiis: 3~9% Radix Clematidis: 2~8%
Rhizoma Arisaematis: 5~11% Radix Aconiti: 3~9% Radix Angelicae Sinensis: 2~8%
Radix Et Rhizoma Rhei: 5~11% Radix Aconiti Kusnezoffii: 3~9% Herba Asaris: 1~7%
Rhizoma Et Radix Notopterygii: 3~9 % Borneolum Syntheticums: 2~8% Camphoras: 10~20%
The optimum ratio scope (by weight percentage) of preparation medicine components of the present invention is:
Herba speranskiae tuberculatae: 7~10% Radix Angelicae Pubescentiss: 4~8% Semen Sinapis Albaes: 2~6%
Give birth to half time: 6~9% Herba Lycopodiis: 4~8% Radix Clematidis: 3~7%
Rhizoma Arisaematis: 6~9% Radix Aconiti: 4~8% Radix Angelicae Sinensis: 3~7%
Radix Et Rhizoma Rhei: 7~10% Radix Aconiti Kusnezoffii: 4~8% Herba Asaris: 2~6%
Rhizoma Et Radix Notopterygii: 4~8% Borneolum Syntheticums: 3~7% Camphoras: 12~17%
Preparing medicine production method of the present invention with above-mentioned each component is:
1, chooses the clean medical material of the high-quality that meets state health standards, meeting processing and preparing under the relevant environment of pharmacy sanitary standard of country;
2, above-mentioned each component is carried out big gun respectively and process, big gun is processed the oven dry of qualified back, drying and crushing to 100 order fine powder again;
3, the fine powder with above-mentioned each component mixes equably in described ratio, obtains mixture;
4, mixture is respectively charged into the plastic pouch packing by constant weight, promptly gets this medicine.
Theory of Chinese medical science is thought cachectic ostealises such as rheumatic arthritis, hyperosteogeny and lumbar muscle strain, mostly because of rheumatism to the marrow, normal cold swelling, or because of overworked, sclerotin produces due to the pathological changes for conforming.This drug invention people is through clinical practice for many years, study assiduously, try to explore, constantly adjust prescription, the ratio of medicine, finally developing the function that this medicine of this medicine has promoting the flow of QI in the collateral by warming the meridian, reducing swelling and alleviating pain, blood circulation promoting and blood stasis dispelling, hard masses softening and resolving, can soften, absorb the hypertrophy sclerotin effectively and deviate from disc tissue, is the active drug of osteopathia such as treatment rheumatic arthritis, hyperosteogeny and lumbar muscle strain, can also be used to treating diseases such as cyclomastopathy, galactocele.
This medicine has following four characteristics:
(1) instant effect, good effect.It has and fundamentally cures common rheumatic arthritis, the unique effects of hyperosteogeny, and the treatment effective percentage is 100%, and cure rate is more than 99%.
(2) short treating period.To general disease, use can reach the purpose of healing one or two course of treatment continuously.
(3) have no side effect.This medicine is formed by 15 kinds of prepared from traditional Chinese medicines, only is used for external application, has no side effect.
(4) cost is low, treatment is convenient.This medicine components mostly is common Chinese herbal medicine, and is cheap, and Therapeutic Method is simple and convenient, is specially adapted to vast town and country patient.
Use this Drug therapy patient's model case as follows:
Case 1: thunder wayside pavilion, man, 32 years old, Xin Dian town, Xinye County, Henan Province Wei Wan people from village.On February 11st, 98 examined, and patient's private prosecution lumbago was had a surplus in 1 year, was diagnosed as lumbar muscle strain, slight L3, L4 lip shape hypertrophy through County Hospital X-ray sheet.Give this medicine three pairs, every secondary three days, through using, the patient just took effect in second day, and waist is not bitterly, and is just fully good after the week, through with examining, do not recur always.
Case 2: Wang Changyan, the man, 22 years old, Xinye County five-pointed star town Tai Zhuan people from village often was engaged in the timber processing industry.On August 23rd, 96 examined, the existing wheat harvesting period of patient's private prosecution waist disease outbreak, and often waist disease had more than 2 years at ordinary times, was diagnosed as L4, L5 prolapse of lumbar intervertebral disc, chronic lumbar muscle strain at county people's hospital's X-ray sheet.Give this medicine fourth officer, the external application affected part, the 3rd day waist of treatment with examining so far, do not recur not bitterly.
Case 3: Wang Suilian, woman, 32 years old, Xinye County five-pointed star town Guo Hu people from village.On March 21st, 96 examined, and patient's private prosecution waist lower limb is pain very, is diagnosed as rheumatic arthritis, chronic sciatica through County Hospital.Give this medicine two pairs, the external application affected part, continuous use five days, second day takes effect, and pain was eliminated fully in the 4th day, with examining so far not recurrence.
Case 4: Sun Mingcai, man, 38 years old, Xinye County Xin Dian town Qiao Zhuan people from village.On January 20th, 97 examined, and patient's private prosecution waist is pain very, also with having a pain in the leg, is diagnosed as prolapse of intervertebral disc, sciatic neuritis through County Hospital.Give this medicine five pairs, medication took effect in second day, and the 4th day is not bitterly, i.e. recovery from illness after 10 days, and with examining so far not recurrence, the patient also is engaged in heavy physical labor always.
Below in conjunction with embodiment the present invention is described in further detail.Embodiment 1:
Take by weighing raw material (unit: restrain) by following proportioning:
Herba speranskiae tuberculatae: 100 Radix Angelicae Pubescentiss: 180 Semen Sinapis Albaes: 20
Give birth to half time: 100 Herba Lycopodiis: 180 Radix Clematidis: 40
Rhizoma Arisaematis: 100 Radix Aconiti: 180 Radix Angelicae Sinensis: 40
Radix Et Rhizoma Rhei: 100 Radix Aconiti Kusnezoffii: 180 Herba Asaris: 40
Rhizoma Et Radix Notopterygii: 180 Borneolum Syntheticums: 160 Camphoras: 40
Preparation method is as follows:
1, chooses the clean medical material of the high-quality that meets state health standards, meeting processing and preparing under the relevant environment of pharmacy sanitary standard of country;
Above-mentioned 15 kinds of medical materials that 2, will take by weighing carry out big gun respectively processs, and big gun is processed the oven dry of qualified back, drying and crushing to 100 order fine powder again;
3, all fine powders are mixed equably, obtain mixture;
4, with mixture evenly be divided into 6 parts, every part of plastic pouch packing of packing into promptly makes this medicine.Embodiment 2:
Take by weighing raw material (unit: gram) by following proportioning
Herba speranskiae tuberculatae: 220 Radix Angelicae Pubescentiss: 60 Semen Sinapis Albaes: 140
Give birth to half time: 220 Herba Lycopodiis: 60 Radix Clematidis: 160
Rhizoma Arisaematis: 220 Radix Aconiti: 60 Radix Angelicae Sinensis: 140
Radix Et Rhizoma Rhei: 220 Radix Aconiti Kusnezoffii: 60 Herba Asaris: 140
Rhizoma Et Radix Notopterygii: 60 Borneolum Syntheticums: 40 Camphoras: 200
Preparation method is identical with embodiment 1.Embodiment 3:
Take by weighing raw material (unit: gram) by following proportioning
Herba speranskiae tuberculatae: 160 Radix Angelicae Pubescentiss: 100 Semen Sinapis Albaes: 80
Give birth to half time: 180 Herba Lycopodiis: 140 CHENGLINGXIAN: 120
Rhizoma Arisaematis: 140 Radix Aconiti: 100 Radix Angelicae Sinensis: 80
Radix Et Rhizoma Rhei: 160 Radix Aconiti Kusnezoffii: 100 Herba Asaris: 80
Rhizoma Et Radix Notopterygii: 140 Borneolum Syntheticums: 120 Camphoras: 300
Preparation method is identical with embodiment 1.

Claims (3)

1, a kind of medicine for the treatment of rheumatic arthritis, hyperosteogeny is characterized in that: it is made (by weight percentage) by following component and is:
Herba speranskiae tuberculatae: 5~11% Radix Angelicae Pubescentiss: 3~9% Semen Sinapis Albaes: 1~7%
Give birth to half time: 5~11% Herba Lycopodiis: 3~9% Radix Clematidis: 2~8%
Rhizoma Arisaematis: 5~11% Radix Aconiti: 3~9% Radix Angelicae Sinensis: 2~8%
Radix Et Rhizoma Rhei: 5~11% Radix Aconiti Kusnezoffii: 3~9% Herba Asaris: 1~7%
Rhizoma Et Radix Notopterygii: 3~9% Borneolum Syntheticums: 2~8% Camphoras: 10~20%
2, the medicine of a kind of treatment rheumatic arthritis as claimed in claim 1, hyperosteogeny is characterized in that: its preferred component ratio range (by weight percentage) is:
Herba speranskiae tuberculatae: 7~10% Radix Angelicae Pubescentiss: 4~8% Semen Sinapis Albaes: 2~6%
Give birth to half time: 6~9% Herba Lycopodiis: 4~8% Radix Clematidis: 3~7%
Rhizoma Arisaematis: 6~9% Radix Aconiti: 4~8% Radix Angelicae Sinensis: 3~7%
Radix Et Rhizoma Rhei: 7~10% Radix Aconiti Kusnezoffii: 4~8% Herba Asaris: 2~6%
Rhizoma Et Radix Notopterygii: 4~8% Borneolum Syntheticums: 3~7% Camphoras: 12~17%
3, a kind of method for preparing treatment rheumatic arthritis as claimed in claim 1 or 2, hyperosteogeny medicine is characterized in that:
(1), choose the clean medical material of the high-quality that meets state health standards, meeting processing and preparing under the relevant environment of pharmacy sanitary standard of country;
(2), above-mentioned each component carried out big gun respectively process, big gun is processed the oven dry of qualified back, drying and crushing to 100 order fine powder again;
(3), the fine powder of above-mentioned each component is mixed equably in described ratio, obtain mixture;
(4), mixture is respectively charged into plastic pouch packing by constant weight, promptly get this medicine.
CN99113955A 1999-03-24 1999-07-28 Medicine for treating rheumatic arthritis and hyperosteogeny and preparing process thereof Expired - Fee Related CN1074676C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN99113955A CN1074676C (en) 1999-03-24 1999-07-28 Medicine for treating rheumatic arthritis and hyperosteogeny and preparing process thereof

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN99113565.2 1999-03-24
CN99113565 1999-03-24
CN99113955A CN1074676C (en) 1999-03-24 1999-07-28 Medicine for treating rheumatic arthritis and hyperosteogeny and preparing process thereof

Publications (2)

Publication Number Publication Date
CN1270053A true CN1270053A (en) 2000-10-18
CN1074676C CN1074676C (en) 2001-11-14

Family

ID=25745046

Family Applications (1)

Application Number Title Priority Date Filing Date
CN99113955A Expired - Fee Related CN1074676C (en) 1999-03-24 1999-07-28 Medicine for treating rheumatic arthritis and hyperosteogeny and preparing process thereof

Country Status (1)

Country Link
CN (1) CN1074676C (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1319566C (en) * 2003-11-19 2007-06-06 蒋介勇 Ointment for treating rheumatic disease
CN102048844B (en) * 2009-11-10 2011-12-21 杨智生 Combined medicament for treating cervical vertebra and lumbar vertebra diseases and preparation method thereof
CN102772753A (en) * 2012-06-14 2012-11-14 薛勇 Traditional Chinese medicine composition for treating hyperosteogeny and preparation method thereof
CN105125978A (en) * 2015-10-20 2015-12-09 万超 Traditional Chinese medicine preparation for treating rheumatic arthritis and preparation method thereof
CN105713789A (en) * 2014-12-01 2016-06-29 重庆畔园猕猴桃股份合作社 Preparation method of health care wine
CN106729264A (en) * 2015-11-19 2017-05-31 哈尔滨圣吉药业股份有限公司 A kind of lopseed dispelling wind and eliminating dampness electuary and preparation method thereof
CN107050402A (en) * 2016-10-28 2017-08-18 曾碧城 Plaster for treating rheumatic ostealgia and preparation method thereof
CN113769001A (en) * 2021-10-29 2021-12-10 鲍香华 Plaster for treating hyperosteogeny and lumbar intervertebral disc protrusion and preparation method thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1026554C (en) * 1989-09-07 1994-11-16 苏宝娟 Production method of a plaster
CN1099983A (en) * 1993-09-09 1995-03-15 袁双田 Medicine for treating rheumatoid or rheumatic arthritis and hyperosteogeny, and method for preparing same

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1319566C (en) * 2003-11-19 2007-06-06 蒋介勇 Ointment for treating rheumatic disease
CN102048844B (en) * 2009-11-10 2011-12-21 杨智生 Combined medicament for treating cervical vertebra and lumbar vertebra diseases and preparation method thereof
CN102772753A (en) * 2012-06-14 2012-11-14 薛勇 Traditional Chinese medicine composition for treating hyperosteogeny and preparation method thereof
CN105713789A (en) * 2014-12-01 2016-06-29 重庆畔园猕猴桃股份合作社 Preparation method of health care wine
CN105125978A (en) * 2015-10-20 2015-12-09 万超 Traditional Chinese medicine preparation for treating rheumatic arthritis and preparation method thereof
CN106729264A (en) * 2015-11-19 2017-05-31 哈尔滨圣吉药业股份有限公司 A kind of lopseed dispelling wind and eliminating dampness electuary and preparation method thereof
CN107050402A (en) * 2016-10-28 2017-08-18 曾碧城 Plaster for treating rheumatic ostealgia and preparation method thereof
CN113769001A (en) * 2021-10-29 2021-12-10 鲍香华 Plaster for treating hyperosteogeny and lumbar intervertebral disc protrusion and preparation method thereof

Also Published As

Publication number Publication date
CN1074676C (en) 2001-11-14

Similar Documents

Publication Publication Date Title
CN1074676C (en) Medicine for treating rheumatic arthritis and hyperosteogeny and preparing process thereof
CN1124156C (en) Chinese-medicinal pills for treating rheumatism and preparing process thereof
CN1772245A (en) Snake medicinal wine for health care massage and its application
CN100344318C (en) Medicine for treating apoplectic sequel and prepn. thereof
CN1186067C (en) Medicine for curing acute injury of muscle and tendon and its preparation method
CN1814180A (en) Collateral-flow-activating pain-relieving medicine of Herba Paederiae
CN1236809C (en) Trauma treating medicament and method for making same
CN1241626C (en) Traditional Chinese medicine composition for treating rheumatic arthritis and atrophic arthritis
CN1112191C (en) Medicine for treating rheumatic arthritis and hyperosteogeny and its preparing process
CN100417405C (en) Collateral-flow-activating pain-relieving medicine of Ramulus et Folium Vaccinii
CN1055002C (en) External-use cream for treatment of breast cancer
CN1857544A (en) Chinese medicine preparation for treating hyperosteogeny
CN1839974A (en) Medicine composition for treating rheumatoid disease and method for preparing the same
CN1273167C (en) Medicine for external application for curing rheumatism and its preparation method
CN1733184A (en) Medicine for curing pyogenic osteomyelitis and process for preparing the same
CN1267526A (en) Compound Chinese medicine preparation for treating hyperosteogeny
CN1313110C (en) Oteoproliferation treating plaster and preparation method thereof
CN100462087C (en) Barban drug for activating collaterals and stopping pain
CN100444832C (en) Medicine for treating pharyngitis
CN1257725A (en) Chinese medicine for treating bone fracture
CN103356965A (en) Drug for curing rheumatoid arthritis
CN1123348C (en) Capsule for treating rheumatic and rheumatoid arthritis and its preparing process
CN1814087A (en) Wind-repellent collateral-activating pain-relieving medicine of Herba clemati dis Intricatae
CN100337669C (en) Externally applied medicine for curing pain and process for preparing the same
CN101804106A (en) Medicine cushion and medicine bag for treating diseases of whole body

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee